Embryonal Hepatoblastoma with Co-existent Glycogen Storage Disease in a Seven-month-old Child

Nadia Shirazi1, Brahma Prakash Kalra2, Nowneet Kumar Bhat3

  • 1Associate Professor, Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University , Jolly Grant, Dehradun, Uttarakhand, India .

Insights

This study reports a rare case of hepatoblastoma, a childhood liver cancer, co-occurring with glycogen storage disease in an infant. This highlights the importance of considering metabolic disorders in pediatric cancer diagnoses.

Area of Science:

  • Pediatric Oncology
  • Hepatology
  • Medical Genetics

Background:

  • Hepatoblastoma is a rare pediatric liver cancer, typically diagnosed in early childhood.
  • Diagnosis relies on histopathology, often preceded by elevated alpha-fetoprotein levels and abdominal mass.
  • While associated with syndromes like FAP and Beckwith-Wiedman, storage disorders are infrequently documented comorbidities.

Observation:

  • A case of an infant male presenting with an abdominal mass and failure to thrive is described.
  • The infant was diagnosed with hepatoblastoma.
  • The patient also had a co-existent glycogen storage disease.

Findings:

  • This case highlights an uncommon co-occurrence of hepatoblastoma and glycogen storage disease.
  • The presentation included a progressively increasing abdominal mass and failure to thrive.
  • Histopathological confirmation was essential for the hepatoblastoma diagnosis.

Implications:

  • This case underscores the need to consider metabolic and storage disorders in the differential diagnosis of pediatric liver tumors.
  • Further research may elucidate potential links between genetic metabolic disorders and hepatoblastoma development.
  • Early identification of co-existing conditions is crucial for comprehensive patient management and treatment strategies.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
997
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K